Horizon Diagnostics Blog

The growing impact of liquid biopsies on precision medicine

Oct 11, 2017 10:30:20 AM No Comments

 Liquid biopsies are becoming increasingly popular in cancer research. We take a look at their potential impact in the clinic and how current technologies can help us keep pushing the boundaries of precision medicine. 

Read More NGS, cfDNA, Reference Standards

SHERLOCK: The case of the disruptive diagnostic

May 10, 2017 2:07:05 PM No Comments

“SHERLOCK is exciting because it represents a sensitive approach to detect mutations, much like PCR, but it does not require a thermocycler and could work as a bedside test.” - Dr Tilmann Buerckstuemmer, Global Head of Innovation at Horizon Discovery

Read More CRISPR, cfDNA

Subscribe to Email Updates

RECENT POSTS